Abstract
Applicability of prostate cancer candidate RNA biomarkers screening in plasma and urine obtained by minimally invasive or noninvasive methods has been demonstrated. In patients with benign prostatic hyperplasia (BPH) significant amounts of RNAs known in the literature as biomarkers associated with prostate cancer have been detected in plasma and urine samples. Detectable amounts of the markers depended on the methods used for transcriptome profiling. Detection of known RNA biomarkers associated with prostate cancer in urine and plasma samples by the RNA-seq method shows its applicability for the search of new RNA biomarkers for minimally invasive diagnostics. However, the fact of the presence of known prostate cancer RNA biomarkers in samples from BPH patients suggests their insufficient specificity and indicates a clear need for further research in this field.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Thompson, I.M., Pauler, D.K., Goodman, P.J., Tangen, C.M., Lucia, M.S., Parneset, H.L. Minasian, L.M., Ford, L.G., Lippman, S.M., Crawford, E.D., Crowley, J.J., and Coltman, C.A., N. Engl. J. Med., 2004, vol. 350, pp. 2239–2246.
Hessels, D., van Gils, M.P., van Hooij, O., Jannink, S.A., Witjes, J.A., Verhaegh, G.W., and Schalken, J.A., Prostate, 2010, vol. 70, pp. 10–16.
Catalona, W., Partin, A., Sanda, M., Wei, J., Klee, G., Bangma, C., Slawin, K.M., Marks, L.S., Loeb, S., Broyles, D.L., Shin, S.S., Cruz, A.B., Chan, D.W., Sokoll, L.J., Roberts, W.L., Ron, H.N. van Schaik, and Mizrahi, I.A., J. Urol., 2011, vol. 185, pp. 1650–1655.
Ross-Adams, H., Lamba, A.D., Dunninga, M.J., Halima, S., Lindbergd, J., Massie, C.M., Egevad, L.A., Russell, R., Ramos-Montoya, A., Vowler, S.L., Sharma, N.L., Kay, J., Whitaker, H., Clark, J., Hurst, R., Gnanapragasam, V.J., Shah, N.C., Warren, A.Y., Cooper, C.S., Lynch, A.G., Stark, R., Mills, I.G., Grönberg, H., and Neal, D.E., EBioMedicine, 2015, vol. 2, pp. 1133–1144.
Tomlins, S.A., Alshalalfa, M., Davicioni, E., Erho, N., Yousefi, K., Zhao, S., Haddad, Z., Den R.B., Dicker, A.P., Trock, B.J., DeMarzo, A.M., Ross, A.E., Schaeffer, E.M., Klein, E.A., Magi-Galluzzi, C., Karnes, R.J., Jenkins, R.B., and Feng, F.Y., Eur. Urol., 2015, vol. 68, pp. 555–567.
Trapnell, C., Roberts, A., Goff, L., Pertea, G., Kim, D., Kelley, D.R., Pimentel, H., Salzberg, S.L., Rinn, J.L., and Pachter, L., Nat. Protoc., 2014, vol. 7, pp. 562–578.
Anders, S., Pyl, P.T., and Huber, W., Bioinformatics, 2014, vol. 31, pp. 166–169.
Costa, V., Angelini, C., De Feis, I., and Ciccodicola, A., J. Biomed. Biotechnol., 2010, vol. 2010:853916. doi 10.1155/2010/853916
Ren, S.I., Wang, F., Shen, J., Sun, Y., Xu, W., Lu, J., Wei, M., Xu, C., Wu, C., Zhang, Z., Gao, X., Liu, Z., Hou, J., Huang, J., and Sun, Y., Eur. J. Cancer., 2013, vol. 49, pp. 2949–2959.
You, J., Cozzi, P., Walsh, B., Willcox, M., Kearsley, J., Russell, P., and Li, Y., Crit. Rev. Oncol. Hematol., 2010, vol. 73, pp. 10–22.
Rönnau, C.G.H., Verhaegh, G.W., Luna-Velez, M.V., and Schalken, J.A., BioMed. Research International, 2014, vol. 591703. doi 10.1155/2014/591703
Mottet, N., Bellmunt, J., Briers, E., van den Bergh, R.C.N., Bolla, M., and van Casteren, N.J., Guidelines on Prostate Cancer, European Association of Urology, 2015, p. 22.
Author information
Authors and Affiliations
Corresponding author
Additional information
Original Russian Text © A.S. Nikitina, V.V. Babenko, K.A. Babalyan, A.O. Vasiliev, A.V. Govorov, E.A. Prilepskaya, S.A. Danilenko, O.V. Selezneva, E.I. Sharova, 2016, published in Biomeditsinskaya Khimiya.
Rights and permissions
About this article
Cite this article
Nikitina, A.S., Babenko, V.V., Babalyan, K.A. et al. Primary screening of candidate RNA biomarkers for diagnostics of prostate cancer. Biochem. Moscow Suppl. Ser. B 10, 180–183 (2016). https://doi.org/10.1134/S1990750816020074
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1134/S1990750816020074